Alexandria Real Estate Equities

AgriMetis, LLC is engaged in the research, development, and production of crop protection products, specifically focusing on fungicides, herbicides, insecticides, and nematicides derived from natural sources. Founded in 2014, the company is headquartered in Lutherville, Maryland, with additional facilities in Research Triangle Park, North Carolina, and a laboratory in Gaithersburg, Maryland. AgriMetis aims to provide sustainable and effective solutions for protecting crops from weeds, fungal diseases, and insect pests, offering farmers safe and cost-effective options for crop management. Its innovative approach combines natural product-derived compounds with advanced production processes to address the challenges faced in agricultural protection.

MacroGenics, Inc. is a biopharmaceutical company based in Rockville, Maryland, specializing in the discovery and development of antibody-based therapeutics for cancer treatment. Founded in 2000, the company focuses on immuno-oncology and has a diverse pipeline of product candidates. Key developments include Margetuximab, a monoclonal antibody in Phase III clinical trials targeting HER2-expressing tumors, and Flotetuzumab, a DART molecule aimed at treating acute myeloid leukemia. Other investigational products include MGA012, MGD013, MGD019, and Enoblituzumab, which target various immune checkpoints and tumor-associated antigens. MacroGenics is also advancing combination therapies and antibody-drug conjugates, such as MGC018, which targets solid tumors expressing B7-H3. The company has formed strategic collaborations with notable partners, enhancing its research and development efforts in the biopharmaceutical landscape.